drugset / Trial / NCT00657891
The Effect of Xolair (Omalizumab) on Allergy Blood Cells
RandomizedParallel-groupTriple-blindBasic science
Summary
We are studying Xolair (omalizumab) to see it's effect on allergic blood cells. The blood tests will be done in a test tube to see if they react differently before and after treatment. The blood cells will be mixed with to whatever the person is allergic.
Timeline
- Start
- 2007-03
- Primary completion
- 2007-10
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omalizumab | Monoclonal antibody | 0.016 mg/kg | Subcutaneous |